VanEck Biotech ETF has outperformed alternative industry ETFs in recent years through its concentration in large-cap leaders. Biotech companies are benefiting from new artificial intelligence tools ...
The executive order aims to reduce drug prices by allowing direct sales to consumers and cutting out PBMs but faces significant challenges. The main risk for biotech is FDA approval delays due to ...
BOSTON--(BUSINESS WIRE)--As the ETF industry reaches a milestone of $12.71 trillion in global assets, the Brown Brothers Harriman 2024 Global ETF Investor Survey finds that investors plan to further ...
BOSTON--(BUSINESS WIRE)--Market volatility and a challenging economic climate have been met with substantial shifts in how and where ETF investors are allocating their capital, according to the ...
Fintel reports that on December 9, 2025, DAY BY DAY downgraded their outlook for VanEck ETF Trust - VanEck Biotech ETF (NasdaqGM:BBH) from Buy to Sell. Analyst Price Forecast Suggests 18.43% Upside As ...
Brown Brothers Harriman (BBH) has implemented its account-opening API with Clearstream to enhance the investor onboarding process. BBH’s account opening API launched in 2024 and is designed to work ...
Are you a print subscriber? Activate your account. 3 hours 3 min ago By Tim Nudd - 13 hours 6 min ago By Adrianne Pasquarelli - 13 hours 16 min ago 15 hours 35 min ago By Elizabeth Moore - 18 hours 42 ...
Tourmaline Partners provides its clients with flexible, front office trading solutions to meet demand for outsourced trading, expected to grow 45% in 2023[http://] [1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback